8SA-12847-28565
2 vaccinations
8 coded responses
17 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 532 / WI
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Survey response — day 0, dose 1MedDRA: Visual impairment — Feeling: Fair · Headache, Fatigue or tirednessFree text: Distorted visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-01
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Just got an hour ago so nothing to report yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Nausea, VomitingAdult check-in
- 2021-04-10
-
2021-04-15
Survey response — day 14, dose 2MedDRA: Metamorphopsia, Nausea, Photophobia — Feeling: GoodFree text: I was out of the country the first week of vaccination but had distorted vision and light sensitivity after the second shot for the first day. I had nausea for two days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — day 21, dose 2MedDRA: Nausea — Feeling: Fair · Be unable to workFree text: Severe nausea the last two weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — day 42, dose 2MedDRA: Gastrointestinal disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Severe GI issues since vaccinatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Dizziness, Impaired gastric emptying — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Have developed gastroparesis and dizzy spells possibly POTSMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-06
- 2021-07-12
- 2021-07-17
-
2021-09-30
Survey response — 6 months, dose 2MedDRA: Flatulence, Post-acute COVID-19 syndrome, Postural orthostatic tachycardia syndrome, Unevaluable event, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Developed POTS and gas tripwires is from the virus and seem tnhave long covid · Healthcare visit (other): Several testing appointments and scansMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-10-01
-
2021-10-01
Call successfulCompleted over the phone
-
2022-04-01
Survey response — 12 months, dose 2MedDRA: Postural orthostatic tachycardia syndrome, Vertigo — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Still have vertigo and POTSMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-05
- 2022-04-08
-
2022-04-08
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 3
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Distorted vision
Release 6 — day 0, dose 2
Systemic reaction (other): Just got an hour ago so nothing to report yet
Release 7 — day 14, dose 2
Symptoms: I was out of the country the first week of vaccination but had distorted vision and light sensitivity after the second shot for the first day. I had nausea for two days.
Release 7 — day 21, dose 2
Symptoms: Severe nausea the last two weeks
Release 8 — day 42, dose 2
Symptoms: Severe GI issues since vaccinated
Release 9 — 3 months, dose 2
Symptoms: Have developed gastroparesis and dizzy spells possibly POTS
Release 9 — 6 months, dose 2
Symptoms: Developed POTS and gas tripwires is from the virus and seem tnhave long covid
Healthcare visit (other): Several testing appointments and scans
Release 11 — 12 months, dose 2
Symptoms: Still have vertigo and POTS
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Flatulence | · | · | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Impaired gastric emptying | ✓ | ✓ | ✓ |
| SD | Metamorphopsia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Photophobia | ✓ | ✓ | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Postural orthostatic tachycardia syndrome | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release